Brazil and Thailand: Activists oppose more TB patents during COVID-19 pandemic
NewsBedaquiline (BDQ) is a core component of an ‘all-oral’ solution to multi-drug resistant TB (MDR-TB), and is recommended by the...
Read more about Brazil and Thailand: Activists oppose more TB patents during COVID-19 pandemic
Civil society asks WHO and Unitaid to ensure equitable access to COVID-19 technologies – and that commitment is binding
Call to action NewsIn an open letter, sent to Unitaid, the World Health Organization (WHO) and its Member States today, 86 civil society...
Activists urge Eurasian states to order more affordable medicines, after HIV patent is dropped
Call to action NewsAbbVie has waived its patent rights for HIV drug, lopinavir/ritonavir (LPV/r), in many parts of the world, including for the...
COVID-19 pandemic: ‘An opportunity of a lifetime’?
News Research The race is on to find an effective treatment and vaccine for COVID-19. Everyone hopes a solution will be...
Read more about COVID-19 pandemic: ‘An opportunity of a lifetime’?
Global headlines: Potential COVID-19 drugs are over-priced
News ResearchFrom the front page of Le Monde, to the Financial Times, Bloomberg, Al Jazeera and others, research demonstrating that potential...
Read more about Global headlines: Potential COVID-19 drugs are over-priced
Postponed: Global Summit on Intellectual Property and Access to Medicines
NewsThe 2020 summit will now take place at a later date, at a time when we are assured that international...
Read more about Postponed: Global Summit on Intellectual Property and Access to Medicines
Open letter: Prepare NOW for equitable access to COVID-19 treatments in Eastern Europe and Central Asia
Call to action NewsOrganizations working on health and rights in the Eastern Europe and Central Asia (EECA) region, have called on governments to...
Possible treatments for COVID-19 could all be made for $1 a day, say researchers: Pharma must not profit from a pandemic and countries must ACT NOW.
Call to action News ResearchDrugs currently being used in COVID-19 treatment trials can all be mass-produced affordably, research from the University of Liverpool, published...
-
Open letter: COVID-19 underlines the need for 37 World Trade Organization members to reverse a critical decision
Call to action NewsAs the International Treatment Preparedness Coalition (ITPC), we have signed an open letter asking 37 World Trade Organization members to...
-
Letter urges Gilead to ensure everyone can access its “promising” COVID-19 treatment pending clinical trial results
Call to action NewsITPC has joined the more than 150 civil society organizations and individuals expressing concerns in a letter to Gilead, coordinated...
